HAART-treated
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Dolutegravir + Rilpivirine Switch Study (DORISS) (NCT02069834) | Nantes University Hospital | 2014-05-01 |
Track HAART-treated automatically
Every clearance here is in the API, with alerts when new ones post.